Clinical features and management of the developmental dysplasia of the hip in congenital muscular torticollis

Pan Gou; Jun Li; Xiang Li; Mingyan Shi; Man Zhang; Peikang Wang; Xing Liu

doi:10.1007/s00264-021-05279-9

Clinical features and management of the developmental dysplasia of the hip in congenital muscular torticollis

Int Orthop. 2022 Apr;46(4):883-887. doi: 10.1007/s00264-021-05279-9. Epub 2022 Jan 8.

Authors

Pan Gou¹, Jun Li¹, Xiang Li¹, Mingyan Shi¹, Man Zhang¹, Peikang Wang¹, Xing Liu²

Affiliations

¹ Department of Orthopedic, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University, No. 136 of Zhong Shan Er Lu, Chongqing, 400014, China.
² Department of Orthopedic, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders Chongqing Key Laboratory of Pediatrics, Children's Hospital of Chongqing Medical University, No. 136 of Zhong Shan Er Lu, Chongqing, 400014, China. liuxingda@126.com.

PMID: 34997287
DOI: 10.1007/s00264-021-05279-9

Abstract

Purpose: A consistent relationship between CMT and DDH has been established. However, whether the presence of CMT has effect on clinical outcomes of DDH remains unanswered. This study aimed to evaluate clinical features and management of DDH in patients with CMT.

Methods: We reviewed the medical records of 54 patients (91 hips) simultaneously diagnosed with DDH and CMT and included 54 patients (97 hips) with only DDH by random number method as the control group. Clinical and examination outcomes were recorded and compared, respectively.

Results: The mean follow-up was 18.1 ± 14.5 months (range, 2 to 72 mo). In the DDH and CMT group, the age of initial treatment was lower (100.8 ± 92.3 vs. 229.0 ± 157.4 d, P < 0.001), and the rate of male significantly increased (42.6% vs. 11.1%, P < 0.001). Before treatment, development degree of hip was better than that of the DDH group. Therefore, patients with CMT had approximately 14 times greater odds of conservative treatment success than children in the DDH group (OR, 13.84; 95% CI, 3.16 to 60.60).

Conclusion: We concluded that CMT was not the risk factor for the failure of treatment. On the contrary, the identification of CMT may be beneficial to early discovery and treatment of DDH when we remain vigilant to perform physical exam and screen imaging of DDH for patients with CMT.

Keywords: Congenital muscular torticollis; Developmental dysplasia of the hip; Features; Management.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Child
Developmental Dysplasia of the Hip*
Hip Dislocation, Congenital* / complications
Hip Dislocation, Congenital* / diagnosis
Hip Dislocation, Congenital* / therapy
Humans
Infant
Male
Retrospective Studies
Torticollis* / congenital
Torticollis* / diagnosis
Torticollis* / etiology
Torticollis* / therapy

Supplementary concepts

Congenital torticollis